← back to search

Dan Gaiță

Institutul National Victor Babes ·
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiac Health and Mental Health, and Cardiovascular Health and Risk Factors.
h-index
39
citations
32,864
works
155
NIH funding
primary concept
Medicine
email

Recent publications

European Society of Cardiology: cardiovascular disease statistics 2021
European Heart Journal 2021cited by 1,097position: middledoi
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
Atherosclerosis 2021cited by 136position: middledoi
World Heart Federation Roadmap for Hypertension – A 2021 Update
Global Heart 2021cited by 132position: middledoi
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
Progress in Cardiovascular Diseases 2021cited by 62position: middledoi
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
European Journal of Preventive Cardiology 2020cited by 913position: middledoi
EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study
European Journal of Preventive Cardiology 2020cited by 743position: middledoi
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries
European Journal of Preventive Cardiology 2020cited by 164position: middledoi
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V
Diabetes Care 2020cited by 79position: middledoi
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis 2019cited by 4,848position: middledoi
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
European Journal of Preventive Cardiology 2019cited by 923position: middledoi
Cardiac Rehabilitation Availability and Density around the Globe
EClinicalMedicine 2019cited by 223position: middledoi
Nature of Cardiac Rehabilitation Around the Globe
EClinicalMedicine 2019cited by 164position: middledoi
Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?
European Journal of Preventive Cardiology 2019cited by 95position: middledoi
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes
Global Heart 2019cited by 36position: middledoi
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study
European Journal of Epidemiology 2018cited by 35position: middledoi
Reconfiguring Cardiac Rehabilitation to Achieve Panvascular Prevention: New Care Models for a New World
Canadian Journal of Cardiology 2018cited by 19position: middledoi
Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions
European Journal of Preventive Cardiology 2016cited by 197position: middledoi
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
Atherosclerosis Supplements 2016cited by 113position: middledoi
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
European Journal of Preventive Cardiology 2015cited by 1,000position: middledoi
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
Cardiovascular Diabetology 2015cited by 145position: middledoi
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery
European Journal of Preventive Cardiology 2012cited by 596position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Laurence Sperling · Emory University2 papers (2018–2019)Kornelia Kotseva · COPE Galway2 papers (2018–2019)Michel Farnier · University of Cape Town1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2012–2012)Lars Rydén · Karolinska Institutet1 papers (2019–2019)Nana Pogosova · Isfahan University of Medical Sciences1 papers (2012–2012)James L. Januzzi · Sentara Heart Hospital1 papers (2019–2019) · 1 papers (2021–2021)Željko Reiner · University Hospital Centre Zagreb1 papers (2021–2021) · 1 papers (2012–2012)Maciej Banach · University of Southampton1 papers (2021–2021)Jorge Plutzky · Harvard University1 papers (2019–2019) · 1 papers (2021–2021)Lijing L. Yan · Duke University1 papers (2021–2021)Éric Bruckert · Sorbonne Université1 papers (2021–2021)Aletta E. Schutte · Alnylam Pharmaceuticals (United States)1 papers (2021–2021)L. Masana · Hospital Universitari Sant Joan de Reus1 papers (2021–2021)Jorge Thierer · Ministerio de Educación1 papers (2019–2019)Patrick Doherty · York University1 papers (2012–2012)